NCT06648746View on ClinicalTrials.gov

Predictors of Therapeutic Success and Adverse Events in Endoscopic Ampullectomy

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Ampulla of Vater AdenomaAmpulla of Vater Disease (Benign/Malignancy)
All Listed Sponsors
lead

Universidade do Porto

OTHER

NCT06648746 - Predictors of Therapeutic Success and Adverse Events in Endoscopic Ampullectomy | Biotech Hunter | Biotech Hunter